Advertisement

Topics

Financial incentives for cholesterol control may be cost-effective

20:00 EDT 13 Sep 2018 | AAAS

(Harvard T.H. Chan School of Public Health) A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health.

Original Article: Financial incentives for cholesterol control may be cost-effective

NEXT ARTICLE

More From BioPortfolio on "Financial incentives for cholesterol control may be cost-effective"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...